Article
Proteomics in prostate cancer biomarker discovery
1 Feb 2010
Abstract excerpt
Despite advances in molecular medicine, genomics, proteomics and translational research, prostate cancer remains the second most common cause of cancer-related mortality for men in the Western world. Clearly, early detection, targeted treatment and post-treatment monitoring are vital tools to combat this disease. Tumor markers can be useful for diagnosis and early detection of cancer, assessment of prognosis,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
